Jin Yang Pharmaceutical Co. Ltd (007370) — Cash Flow Reinvestment Rate
Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow Reinvestment Rate of 0.44x as of March 2026, reinvesting ₩1.99 Billion (capex ₩197.80 Million plus investments ₩-1.79 Billion) from operating cash flow of ₩4.53 Billion. Check cash flow quality index of Jin Yang Pharmaceutical Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jin Yang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Jin Yang Pharmaceutical Co. Ltd across 8 annual periods. Explore how much of Jin Yang Pharmaceutical Co. Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jin Yang Pharmaceutical Co. Ltd (2018–2025)
Year-by-year capital reinvestment analysis for Jin Yang Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see 007370 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.67x | ₩3.92 Billion | ₩1.46 Billion | ₩3.67 Billion | ▼ -60.8% |
| 2024 | 6.82x | ₩87.22 Billion | ₩12.79 Billion | ₩947.22 Million | ▲ +1120.0% |
| 2023 | 0.56x | ₩4.77 Billion | ₩8.53 Billion | ₩1.53 Billion | ▼ -62.7% |
| 2022 | 1.50x | ₩11.17 Billion | ₩7.45 Billion | ₩3.22 Billion | ▼ -26.9% |
| 2021 | 2.05x | ₩4.04 Billion | ₩1.97 Billion | ₩2.52 Billion | ▲ +191.0% |
| 2020 | 0.71x | ₩4.41 Billion | ₩6.24 Billion | ₩1.36 Billion | ▲ +198.1% |
| 2019 | 0.24x | ₩1.71 Billion | ₩7.21 Billion | ₩736.71 Million | ▼ -41.7% |
| 2018 | 0.41x | ₩429.64 Million | ₩1.06 Billion | ₩327.39 Million | — |